Dabur has sold Chyawanprash, an ayurvedic paste attributed to the sage Chyawan, for close to a century, positioned in largely the same way across generations: a spoonful a day for general immunity and wellness.
It is not a product that ever needed a repositioning campaign. When COVID-19 reached India in 2020 and immunity became the single most searched health concern in the country almost overnight, demand for Chyawanprash surged so sharply that Dabur had to significantly ramp up manufacturing capacity just to keep shelves stocked. The wider ayurvedic immunity category, giloy, kadha mixes, chyawanprash, grew into one of the fastest expanding corners of Indian FMCG through 2020 and 2021.
Dabur didn’t have to convince anyone that Chyawanprash was relevant to a pandemic. It had spent a hundred years building exactly that association, quietly, long before there was a pandemic to make it urgent. When the market’s mood shifted overnight toward precisely what the brand already stood for, the only job left was manufacturing enough of it.
ITC’s acquisition of Yoga Bar shows a large FMCG player buying its way into the same health territory Dabur had already owned for decades. WOW Skin Science’s ingredient-led trust building runs on a similar principle, just built far faster and more recently. Licious‘s entire brand is built around addressing one specific consumer fear, the same structural insight that made Chyawanprash’s immunity promise so valuable the moment fear of illness spiked nationwide.
Patience, in this case, paid out in a single quarter what decades of steady sales had never delivered.
